Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)

Ageing Research Reviews

Volumn 8, Issue 4, 2009, Pages 349-358

  Arjamaa, Olli ^a   Nikinmaa, Mikko ^a   Salminen, Antero ^b,c   Kaarniranta, Kai ^b,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

AMD; Hypoxia; Inflammation; Oxidative stress

Indexed keywords

HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOFUSCIN; REACTIVE OXYGEN METABOLITE;

AUTOPHAGY; BRUCH MEMBRANE; CELL AGING; CHRONIC INFLAMMATION; DRUG TARGETING; DRUSEN; HUMAN; HYPOXIA; OXIDATIVE STRESS; PATHOGENESIS; PERFUSION; PIGMENT EPITHELIUM; PROTEIN FUNCTION; RETINA BLOOD FLOW; RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; SUBRETINAL NEOVASCULARIZATION; TRANSCRIPTION REGULATION;

AGE FACTORS; AGING; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACULAR DEGENERATION; NF-KAPPA B; RETINAL PIGMENT EPITHELIUM;

EID: 69049088683     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2009.06.002     Document Type: Short Survey

References (170)

1. Algvere P.V., and Seregard S. Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?. Acta Ophthalmol. Scand. 81 (2003) 427-429
2. Al-Shabrawey M., Rojas M., Behzadian A., El-Remessay A., Bartoli M., Parpia A.K., Liou G., and Caldwell R.B. Role of NADPH in retinal inflammation. Invest. Ophthalmol. Vis. Sci. 49 (2008) 3239-3244
3. Ambati J., Ambati B.K., Yoo S.H., Ianchulev S., and Adamis A.P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48 (2003) 257-293
4. Anderson D.H., Mullins R.F., Hageman G.S., and Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134 (2002) 411-431
5. Arjamaa O., and Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 83 (2006) 473-483
6. Arjamaa O., and Nikinmaa M. Natriuretic peptides in hormonal regulation of hypoxia responses. Am. J. Physiol. 286 (2009) R257-R264
7. Beatty S., Koh H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45 (2000) 115-134
8. Belaiba R.S., Bonello S., Zähringer C., Schmidt S., Hess J., Kietzmann T., and Görlach A. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol. Biol. Cell. 18 (2007) 4691-4697
9. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouysségur J., and Mazure N.M. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29 (2009) 2570-2581
10. Berra E., Milanini J., Richard D.E., Le Gall M., Vinals F., Gothie E., Roux D., Pages G., and Pouyssegur J. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem. Pharmacol. 60 (2000) 1171-1178
11. Berra E., Benizri E., Ginouvés A., Volmat V., Roux D., and Pouysségur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 22 (2003) 4082-4090
12. Berra E., Ginouvés A., and Pouysségur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 7 (2005) 41-45
13. 2 availability on human cancer. Nat. Rev. Cancer 8 (2008) 967-975
14. Bonello S., Zähringer C., BelAiba R.S., Djordjevic T., Hess J., Michiels C., Kietzmann T., and Görlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFκB site. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 755-761
15. Boon C.J., Klevering B.J., Hoyng C.B., Zonneveld-Vrieling M.N., Nabuurs S.B., Blokland E., Cremers F.P., and den Hollander A.I. Basal laminal drusen caused by compound heterozygous variants in the CFH gene. Am. J. Genet. 82 (2008) 516-523
16. Boulton M., and Dayhaw-Barker P. The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye 15 (2001) 384-389
17. Boulton M., Dontsov A., Jarvis-Evans J., Ostrovsky M., and Svistunenko D. Lipofuscin is a photoinducible free radical generator. J. Photochem. Photobiol. B 19 (1993) 201-204
18. Brahimi-Horn M.C., and Pouyssegúr J. Oxygen, a source of life. FEBS Lett. 581 (2007) 3582-3591
19. Bressler N.M., Bressler S.B., and Fine S.L. Age-related macular degeneration. Surv. Ophthalmol. 32 (1988) 375-413
20. Buch H., Vinding T., la Cour M., Jensen G.B., Prausem J.U., and Nielsen N.V. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol. Scand. 83 (2005) 409-418
21. Calzada M.J., and del Peso L. Hypoxia-inducible factors and cancer. Clin. Transl. Oncol. 9 (2007) 278-289
22. Cash T.P., Pan Y., and Simon M.C. Reactive oxygen species and cellular oxygen sensing. Free Radical Biol. Med. 43 (2007) 1219-1225
23. Cherniak N.S. Oxygen sensing: application in humans. J. Appl. Physiol. 96 (2004) 352-358
24. Chowdhury R., Hardy A., and Schofield C.J. The human oxygen sensing machinery and its manipulation. Chem. Soc. Rev. 37 (2008) 1308-1319
25. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Carter C., Yu B.P., and Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8 (2009) 18-30
26. Cockman M.E., Masson N., Mole D.R., Jaakkola P., Chang G.W., Clifford S.C., Maher E.R., Pugh C.W., Ratcliffe P.J., and Maxwell P.H. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275 (2000) 25733-25741
27. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., and Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14682-14687
28. Decanini A., Nordgaard C.L., Feng X., Ferrington D.A., and Olsen T.W. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am. J. Ophthalmol. 143 (2007) 607-615
29. Donoso L.A., Kim D., Frost A., Callahan A., and Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 51 (2006) 137-152
30. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
31. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., and Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4273-4278
32. Ennis S., Jomary C., Mullins R., Cree A., Chen X., MacLeod A., Jones S., Collins A., Stone E., and Lotery A. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 372 (2008) 1828-1834
33. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-45
34. Eskelinen E.L. New insights into the mechanisms of macroautophagy in mammalian cells. Int. Rev. Cell Mol. Biol. 266 (2008) 207-247
35. Fandrey J., Gorr T.A., and Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc. Res. 71 (2006) 642-651
36. Fooroghian F., Razavi R., and Timms L. Hypoxia-inducible factor expression in human RPE cells. Br. J. Ophthalmol. 91 (2007) 1406-1410
37. Francis P.J., Schulz D.W., Hamon S., Ott J., Weleber R.G., and Klein M.L. Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One 2 (2007) e1197
38. Frede S., Berchner-Pfannschmidt U., and Fandrey J. Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol. 435 (2007) 405-419
39. Frede S., Stockmann C., Freitag P., and Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem. J. 396 (2006) 517-527
40. Frede S., Stockmann C., Winning S., Freitag P., and Fandrey J. Hypoxia-inducible factor (HIF) 1alpha accumulation and HIF target gene expression are impaired after induction of endotoxin tolerance. J. Immunol. 182 (2009) 6470-6476
41. Fähling M. Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia. Acta Physiol. 195 (2009) 205-230
42. Gehrs K.M., Anderson D.H., Johnson V., and Hageman G.S. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann. Med. 38 (2006) 450-471
43. Grunwald J.E., Metelitsina T.I., Dupont J.C., Ying G.S., and Maguire M.G. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest. Ophthalmol. Vis. Sci. 45 (2005) 1033-1038
44. Gu Y.Z., Moran S.M., Hogenesch J.B., Wartman L., and Bradfield C.A. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Express. 7 (1998) 205-213
45. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchhardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., and Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 7227-7232
46. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20 (2001) 705-732
47. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Nouredienne M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., and Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
48. Hardarson S.H., Harris A., Karlsson R.A., Halldorsson G.H., Kagemann L., Rechtman E., Zoega G.M., Eysteinsson T., Benediktsson J.A., Thorsteinsson A., Jensen P.K., Beach J., and Stefánsson E. Automatic retinal oximetry. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5011-5016
49. Heidbreder M., Fröhlich F., Jöhren O., Dendorfer A., Qadri F., and Dominiak P. Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J. 17 (2003) 1541-1544
50. Heidbreder M., Qadri F., Jöhren O., Dendorfer A., Depping R., Fröhlich F., Wagner K.F., and Dominiak P. Non-hypoxic induction of HIF-3alpha by 2-deoxy-d-glucose and insulin. Biochem. Biophys. Res. Commun. 352 (2007) 437-443
51. Hickey M.M., and Simon M.C. Regulation of angiogenesis by hypoxia-inducible factors. Curr. Top. Dev. Biol. 76 (2006) 217-257
52. Hirsilä M., Koivunen P., Günzler V., Kivirikko K.I., and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278 (2003) 30772-30780
53. Hirvelä H., Luukinen H., Läärä E., and Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103 (1996) 871-877
54. Hjelmeland L.M., Cristofolo V.J., Funk W., Rakoczy E., and Katz M.L. Senescence of the retinal pigment epithelium. Mol. Vis. 5 (1999) 33
55. Holz F.G., Bindewald-Wittich A., Fleckenstein M., Dreyhaupt J., Scholl H.P., Schmitz-Valckenberg S., and FAM-Study Group. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am. J. Ophthalmol. 143 (2007) 463-472
56. Holz F.G., Pauleikhoff D., Spaide R.F., and Bird A.C. Genetics of AMD. In: Holz F.G., Pauleikhoff D., Spaide R.F., and Bird A.C. (Eds). Age-related Macular Degeneration (2004), Springer-Verlag, Berlin/Heidelberg 24-30
57. Howes K.A., Liu Y., Dunaief J.L., Milam A., Frederick J.M., Marks A., and Baehr W. Receptor for advanced glycation end products and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3713-3720
58. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7987-7992
59. Hutchinson A.K., Grossniklaus H.E., and Capone A. Giant-cell reaction in surgically excised subretinal neovascular membrane. Arch. Ophthalmol. 111 (1993) 734-735
60. Inoue Y., Yanagi Y., Matsuura K., Takahashi H., Tamaki Y., and Araie M. Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br. J. Ophthalmol. 91 (2007) 1720-1721
61. Iwai K., Yamanaka K., Kamura T., Minato N., Conaway R.C., Conaway J.W., Klausner R.D., and Pause A. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12436-12441
62. Iyer N.V., and Leung S.W. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 52 (1998) 159-165
63. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
64. Jaakkola P.M., and Pursiheimo J.P. p62 degradation by autophagy: another way for cancer cells to survive under hypoxia. Autophagy 5 (2009) 410-412
65. Jiang B.H., Rue E., Wang G.L., Roe R., and Semenza G.L. Dimerization, DNA, binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996) 17771-21778
66. Johnson L.V., Leitner W.P., Staples M.K., and Anderson D.H. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp. Eye Res. 73 (2001) 887-896
67. Kaarniranta K., and Salminen A. Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors. J. Mol. Med. 87 (2009) 117-123
68. Kaarniranta K., Ryhänen T., Karjalainen H.M., Lammi M.J., Suuronen T., Huhtala A., Kontkanen M., Terasvirta M., Uusitalo H., and Salminen A. Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells. Neurosci. Lett. 382 (2005) 185-190
69. Kaarniranta K., Salminen A., Eskelinen E.L., and Kopitz J. Heat shock proteins as gatekeepers of proteolytic pathways-implications for age-related macular degeneration (AMD). Ageing Res. Rev. 8 (2009) 128-139
70. Kamura T., Sato S., Iwai K., Czyzyk-Krzeska M., Conaway R.C., and Conaway J.W. Activation of HIF-1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10430-10435
71. Kaelin W.G., and Ratcliffe P.J. Oxygen sensing by metazoan: the central role of the HIF hydroxylase pathway. Mol. Cell 30 (2008) 393-402
72. Kaluz S., Kaluzova M., and Stanbridge E.J. The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. J. Cell. Biochem. 97 (2006) 207-216
73. Kang K.H., Lemke G., and Kim J.W. The PI3K-PTEN tug-of-war, oxidative stress and retinal degeneration. Trends Mol. Med. 15 (2009) 191-1988
74. Ke Q., and Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70 (2006) 1469-1480
75. Kenneth N.S., and Rocha S. Regulation of gene expression by hypoxia. Biochem. J. 414 (2008) 19-29
76. Kietzmann T., Jungermann K., and Gorlach A. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb. Haemost. 89 (2003) 666-673
77. Killingsworth M.C., Sarks J.P., and Sarks S.H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 4 (1990) 613-621
78. Kivirikko K.I., and Myllyharju J. Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 16 (1998) 357-368
79. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., San Giovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
80. Kociok N., Krohne T.U., Poulaki V., and Joussen A.M. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 245 (2007) 258-266
81. Kong X., Lin Z., Liang D., Fath D., Sang N., and Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol. Cell Biol. 26 (2006) 2019-2028
82. Kurz T., Karlsson M., Brunk U.T., Nilsson S.E., and Frennesson C. ARPE-19 retinal pigment epithelial cells are highly resistant to oxidative stress and exercise strict control over their lysosomal redox-active iron. Autophagy 5 (2009) 494-501
83. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1929-1934
84. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
85. Lee S.M., Lee C.T., Kim Y.W., Han S.K., Shim Y.S., and Yoo C.G. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett. 242 (2006) 231-238
86. Listwan J., Imbert G., Wirbelauer C., Gstaiger M., and Krek W. The von Hippel-Lindau tumour suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 13 (1999) 1822-1833
87. Lisy K., and Peet D.J. Turn me on: regulating HIF transcriptional activity. Cell Death Differ. 15 (2008) 642-649
88. Loane E., Kelliher C., Beatty S., and Nolan J.M. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br. J. Ophthalmol. 92 (2008) 1163-1168
89. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin Jr. A.S., and Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20 (2000) 1626-1638
90. Mahon P.C., Hirota K., and Semenza G.L. FIH-1, a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15 (2001) 2675-2686
91. Maller J.B., Fagerness J.A., Reynolds R.C., Neale B.M., Daly M.J., and Seddon J.M. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 39 (2007) 1200-1201
92. Marshall J. The ageing retina: physiology or pathology. Eye 1 (1987) 282-295
93. Martin G., Schlunck G., Hansen L.L., and Agostini H.T. Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch. Clin. Exp. Ophthalmol. 242 (2004) 321-326
94. Martinez-Vicente M., Sovak G., and Cuervo A.M. Protein degradation and aging. Exp. Gerontol. 40 (2005) 622-633
95. Mayer M.P., and Bukau B. Molecular chaperones: the busy life of Hsp90. Curr. Biol. 9 (1999) 322-325
96. Meri S. Loss of self-control in the complement system and innate autoreactivity. Ann. N.Y. Acad. Sci. 1109 (2007) 93-105
97. Metelitsina T.I., Grunwald J.E., DuPont J.C., Ying G.S., Brucker A.J., and Dunaief J.L. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 49 (2008) 358-363
98. Minet E., Arnould T., Michel G., Roland I., Mottet D., Raes M., Remacle J., and Michiels C. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468 (2000) 53-58
99. Montezuma S.R., Sobrin L., and Seddon J.M. Review of genetics in age related macular degeneration. Semin Ophthalmol. 22 (2007) 229-240
100. Morimoto R.I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22 (2008) 427-1438
101. Mottet D., Dumont V., Deccache Y., Demazy C., Ninane N., Raes M., and Michiels C. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J. Biol. Chem. 278 (2003) 31277-31285
102. Mottet D., Michel G., Renard P., Ninane N., Raes M., and Michiels C. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol. 194 (2003) 30-44
103. Mullins R.F., Russell S.R., Anderson D.H., and Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14 (2000) 835-846
104. Mylonis I., Chachami G., Samiotaki M., Panayotou G., Paraskeva E., Kalousi A., Georgatsou E., Bonanou S., and Simos G. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J. Biol. Chem. 281 (2006) 33095-33106
105. Neckers L., and Ivy S.P. Heat shock protein 90. Curr. Opin. Oncol. 15 (2003) 419-424
106. Ng T.K., Chen L.J., Liu D.T.L., Tam P.O.S., Chan W.M., Liu K., Hu Y.J., Chong K.K.L., Lau C.L., Chiang S.W.Y., Lam D.S.C., and Pang C.P. Multiple gene polymorphisms in the complement factor H gene are associated with exudative age-related macular degeneration in Chinese. Invest. Ophthalmol. Vis. Sci. 49 (2008) 3312-3317
107. Nordgaard C.L., Karunadharma P.P., Feng X., Olsen T.W., and Ferrington D.A. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 49 (2008) 2848-2855
108. Ohh M., Park C.W., Ivan M., Hoffman M.A., Kim T.Y., Huang L.E., Pavletich N., Chau V., and Kaelin W.G. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nature Cell Biol. 2 (2000) 423-427
109. Otrock Z.K., Hatoum H.A., Awada A.H., Ishak R.S., and Shamseddine A.I. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit. Rev. Oncol. Hematol. (2009) (Epub ahead of print)
110. Park K.H., Ryu E., Tosakulwong N., Wu Y., and Edwards A.O. Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects. Mol. Vis. 15 (2009) 200-2007
111. Pauleikhoff D., Barondes M.J., Minassian D., Chisholm I.H., and Bird A.C. Drusen as risk factors in age-related macular disease. Am. J. Ophthalmol. 109 (1990) 38-43
112. Pearl L.H., and Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu. Rev. Biochem. 75 (2006) 271-294
113. Pearl L.H., Prodromou C., and Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 410 (2008) 439-453
114. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch. Clin. Exp. Ophthalmol. 223 (1985) 69-76
115. Pillunat L.E. Ocular blood flow endpoints. Eur. J. Ophthalmol. 9 Suppl. 1 (1999) S44-S47
116. Pournaras C.J., Rungger-Brändle E., Riva C.E., Hardarson S.H., and Stefánsson E. Regulation of retinal blood flow in health and disease. Prog. Retin. Eye Res. 27 (2008) 286-330
117. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
118. Rankin E.B., and Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15 (2008) 678-685
119. Rapino C., Bianchi G., Di Giulio C., Centurione L., Cacchio M., Antonucci A., and Cataldi A. HIF-1alpha cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Aging Cell 4 (2005) 177-185
120. Richter K., Muschler P., Hainzl O., and Buchner J. Coordinated ATP hydrolysis by the Hsp90 dimer. J. Biol. Chem. 276 (2001) 33689-33696
121. Rissanen E., Tranberg H.K., Sollid J., Nilsson G.E., and Nikinmaa M. Temperature regulates hypoxia-inducible factor-1 (HIF-1) in a poikilothermic vertebrate, crucian carp (Carassius carassius). J. Exp. Biol. 209 (2006) 994-1003
122. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., and Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 (2008) 807-811
123. Ryhänen T., Mannermaa E., Oksala N., Viiri J., Paimela T., Salminen A., Atalay M., and Kaarniranta K. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells. Eur. J. Pharmacol. 584 (2008) 229-236
124. Ryhänen T., Hyttinen J.M., Kopitz J., Rilla K., Kuusisto E., Mannermaa E., Viiri J., Holmberg C.I., Immonen I., Meri S., Parkkinen J., Eskelinen E.L., Uusitalo H., Salminen A., and Kaarniranta K. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J. Cell. Mol. Med. (2008) [November 6, Epub ahead of print]
125. Salminen A., and Kaarniranta K. Regulation of the aging process by autophagy. Trends Mol. Med. (2009) [April 18, Epub ahead of print]
126. Salminen A., Ojala J., Huuskonen J., Kauppinen A., Suuronen T., and Kaarniranta K. Interaction of aging-associated signaling cascades: inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1. Cell. Mol. Life Sci. 65 (2008) 1049-1058
127. Sarkar D., and Fisher P.B. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 236 (2006) 13-23
128. Schlingemann R.O. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 242 (2004) 91-101
129. Schnitzer S.E., Schmid T., Zhou J., Eisenbrand G., and Brune B. Inhibition of GSK3beta by indirubins restores HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia. FEBS Lett. 579 (2005) 529-533
130. Scroggins B.T., Robzyk K., Wang D., Marcu M.G., Tsutsumi S., Beebe K., Cotter R.J., Felts S., Toft D., Karnitz L., Rosen N., and Neckers L. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell. 225 (2007) 151-159
131. Seddon J.M., Cote J., Page W.F., Aggen S.H., and Neale M.C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch. Ophthalmol. 123 (2005) 321-327
132. Seitsonen S., Lemmelä S., Holopainen J., Tommila P., Ranta P., Kotamies A., Moilanen J., Palosaari T., Kaarniranta K., Meri S., Immonen I., and Järvelä I. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. Mol. Vis. 12 (2006) 796-801
133. Seitsonen S.P., Onkamo P., Peng G., Xiong M., Tommila P.V., Ranta P.H., Holopainen J.M., Moilanen J.A., Palosaari T., Kaarniranta K., Meri S., Immonen I.R., and Järvelä I.E. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One 3 (2008) e3833
134. Seregard S., Algvere P.V., and Berglin L. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch. Clin. Exp. Ophthalmol. 232 (1994) 325-329
135. Semenza G.L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14 (2000) 1983-1991
136. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
137. Semenza G.L. Life with oxygen. Science 318 (2007) 62-64
138. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12 (1992) 5447-5454
139. Shimada H., Kawamura A., Mori R., and Yuzawa M. Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch. Clin. Exp. Ophthalmol. 245 (2007) 295-300
140. Sizemore N., Leung S., and Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 19 (1999) 4798-4805
141. Smith W., Mitchell P., and Leeder S.R. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch. Ophthalmol. 114 (1996) 1518-1523
142. Smith T.G., Robbins P.A., and Ratcliffe P.J. The human side of hypoxia-inducible factor. Br. J. Haematol. 141 (2008) 325-334
143. Sparrow J.R., Cai B., Fishkin N., Jang Y.P., Krane S., Vollmer H.R., Zhou J., and Nakanishi K. A2E, a fluorophore of RPE lipofuscin: can it cause RPE degeneration?. Adv. Exp. Med. Biol. 533 (2003) 205-211
144. Spilsbury K., Garrett K.L., Shen W.Y., Constable I.J., and Rakoczy P.E. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am. J. Pathol. 157 (2000) 135-144
145. Stockman C., and Fandrey J. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression. Clin. Exp. Pharmacol. Physiol. 33 (2006) 968-979
146. Suter M., Remé C., Grimm C., Wenzel A., Jäättelä M., Esser P., Kociok N., Leist M., and Richter C. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275 (2000) 39625-39630
147. Tanimoto K., Makino Y., Pereira T., and Poellinger L. Mechanism of regulation of the hypoxia-inducible factor 1alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19 (2000) 4298-4309
148. Taylor C.T. Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation. J. Physiol. 586 (2008) 4055-4059
149. Terman A., and Brunk U.T. Lipofuscin. Int. J. Biochem. Cell Biol. 36 (2004) 1400-1404
150. Tian H., McKnight S.L., and Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11 (1997) 72-82
151. Treinin M., Shliar J., Jiang H., Powell-Coffman J.A., Bromberg Z., and Horowitz M. HIF-1 is required for heat acclimation in the nematode Caenorhabditis elegans. Physiol. Genom. 14 (2003) 17-24
152. Trick G.L., and Berkowitz B.A. Retinal oxygenation response and retinopathy. Prog. Retin. Eye Res. 24 (2005) 259-274
153. Tolppanen A.M., Nevalainen T., Kolehmainen M., Seitsonen S., Immonen I., Uusitupa M., Kaarniranta K., and Pulkkinen L. Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration. Mol. Vis. 15 (2009) 762-770
154. Ushio-Fukai M., and Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 266 (2008) 37-52
155. van Leeuwen R., Ikram M.K., Vingerling J.R., Witteman J.C., Hofman A., and de Jong P.T. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3771-3777
156. van Uden P., Kenneth N.S., and Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem. J. 412 (2008) 477-484
157. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5510-5514
158. Wang A.L., Lukas T.J., Yuan M., Du N., Tso M.O., and Neufeld A.H. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One 24 (2009) e4160
159. Wangsa-Wirawan N.D., and Linsenmeier R.A. Retinal oxygen. Fundamental and clinical aspects. Arch. Ophthalmol. 121 (2003) 547-557
160. Winkler B.S., Boulton M.E., Gottsch J.D., and Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 5 (1999) 32
161. Wu W.C., Kao Y.H., Hu P.S., and Chen J.H. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro. Exp. Eye Res. 85 (2007) 721-731
162. Xing C., Sivakumaran T.A., Wang J.J., Rochtchina E., Joshi T., Smith W., Mitchell P., and Iyengar S.K. Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study. Genes Immun. 9 (2008) 231-239
163. Yamada Y., Ishibashi K., Ishibashi K., Bhutto I.A., Tian J., Lutty G.A., and Handa J.T. The expression of advanced glycation endproduct receptors in RPE cells associated with basal deposits in human maculas. Exp. Eye Res. 82 (2006) 840-848
164. Yates J.R., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., Armbrecht A.M., Dhillon B., Deary I.J., Redmond E., Bird A.C., Moore A.T., and Genetic Factors in AMD Study Group. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357 (2007) 553-561
165. Yu D.Y., and Cringle S.J. Retinal degeneration and local oxygen metabolism. Exp. Eye Res. 80 (2005) 745-751
166. 2+ signaling, prolyl hydroxylases, and mTOR. J. Cell. Physiol. 217 (2008) 674-685
167. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., and Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283 (2008) 10892-10903
168. Zhang P., Wang Y., Hui Y., Hu D., Wang H., Zhou J., and Du H. Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica 221 (2007) 411-417
169. Zhao W., Wang Y.S., Hui Y.N., Zhu J., Zhang P., Li X., and Dou G.R. Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1alpha with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system. Graefes Arch. Clin. Exp. Ophthalmol. 246 (2008) 1413-1422
170. Zinkernagel A.S., Johnson R.S., and Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. 85 (2007) 1339-1346